Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
NCT Number: NCT02181140
The study is designed to evaluate the diagnostic accuracy of a new designed endoscopic ultrasonography (EUS) Core biopsy aspiration needle in comparison to a conventional EUS aspiration needle in GI-tumors.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hamburg, 20246, Germany
Endoscopic ultrasound is an established examination method for tumors of the gastrointestinal tract and the pancreas. Since imaging by itself is limited in differential diagnosis of tumors, EUS guided fine needle aspiration is seen as a valid complementary method. Since fine-needle aspiration (FNA) is mainly based on cytological diagnostics, this method is limited also because of lacking supplementary immune- histochemical diagnostics. Here, the obtainment of little histologically evaluable tissue samples (punched barrels) would be of benefit.
A new punch needle device called Pro-core needle (Cook)(22 / 19 gauges) offers the possibility of increasing numbers of valid extractions of histologically evaluable tissues due to a better targeted precision and maneuverability in comparison to other devices of that kind (tru-cut needles, e.g.). A little notch at the pinpoint allows the obtainment of little tissue samples, that will be kept within the device by aspiration.
This study compares the obtainment of tissue by Proc-core needle and conventional aspiration punction systems.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
punction of a suspect area by a EUS guided fine needle as well as pro core fine needle to evacuate histology and smear biologics
Time frame: up to 1 year
Diagnostic accuracy of Pro-core needle (22 G) will be compared to conventional fine needle aspiration (22 G). Therefore EUS-FNA with both needles is undertaken in a random order in each lesion. For Pro-core needle, a histological / cytological diagnosis and quality assessment will be made by pathologists.For Echotip aspiration needle, reference cytology evaluation is done by cytology experts.
The histopathological diagnosis after surgery or the clinical follow up of at least one year after EUS FNA is current standard.
Time frame: day 0 and day 14
Histology (not cytology) samples for Pro-core Needle: Number of adequately evaluable histology samples
Time frame: day 0 and day 14
Complication rates of EUS FNA
Universitätsklinikum Hamburg-Eppendorf
Other
Prospective Evaluation of the Significance of the Pro-core® Needle in Differential Diagnosis of Tumorous and Inflammatory Processes
Acronym: COS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03310632
Digestive System Diseases, Digestive System Neoplasms
Tampa, Florida, United States
View Trial DetailsNCT07252570
Biliary Tract Diseases, Biliary Tract Neoplasms
Nice, Alpes Maritimes, France
View Trial DetailsNCT07045181
Chronic Disease, Chronic Pancreatitis
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03033225
Advanced Pancreatic Carcinoma, Digestive System Diseases
Rochester, Minnesota, United States
View Trial Details